Metabolic Reprogramming by Andrographolide: Enhanced Pentose Phosphate Pathway and Antioxidant Capacity in Cortical Astrocytes
Abstract
Share and Cite
Cisternas, P.; Ormazabal, P.; Gherardelli, C.; Bastías-Pérez, M.; Brito-Valenzuela, J.; Inestrosa, N.C. Metabolic Reprogramming by Andrographolide: Enhanced Pentose Phosphate Pathway and Antioxidant Capacity in Cortical Astrocytes. Pharmaceuticals 2026, 19, 133. https://doi.org/10.3390/ph19010133
Cisternas P, Ormazabal P, Gherardelli C, Bastías-Pérez M, Brito-Valenzuela J, Inestrosa NC. Metabolic Reprogramming by Andrographolide: Enhanced Pentose Phosphate Pathway and Antioxidant Capacity in Cortical Astrocytes. Pharmaceuticals. 2026; 19(1):133. https://doi.org/10.3390/ph19010133
Chicago/Turabian StyleCisternas, Pedro, Paulina Ormazabal, Camila Gherardelli, Marianela Bastías-Pérez, Jose Brito-Valenzuela, and Nibaldo C. Inestrosa. 2026. "Metabolic Reprogramming by Andrographolide: Enhanced Pentose Phosphate Pathway and Antioxidant Capacity in Cortical Astrocytes" Pharmaceuticals 19, no. 1: 133. https://doi.org/10.3390/ph19010133
APA StyleCisternas, P., Ormazabal, P., Gherardelli, C., Bastías-Pérez, M., Brito-Valenzuela, J., & Inestrosa, N. C. (2026). Metabolic Reprogramming by Andrographolide: Enhanced Pentose Phosphate Pathway and Antioxidant Capacity in Cortical Astrocytes. Pharmaceuticals, 19(1), 133. https://doi.org/10.3390/ph19010133

